+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Plasmodium falciparum malaria: type R1 quinine resistance in West Africa



Plasmodium falciparum malaria: type R1 quinine resistance in West Africa



Presse Medicale 27(11): 522



The case is reported of a 26-year-old man who had returned to France after a 2-year stay in Ghana (without chemoprophylaxis); he had visited Togo and Benin in the preceding 2 months. He presented with malaria and was treated with parenteral quinine (1500 mg/day for 7 days). Apyrexia occurred after 5 days of treatment, and a thick blood smear was negative after 4 days.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 003233742

Download citation: RISBibTeXText


Related references

Plasmodium falciparum malaria: type R1 resistance to quinine in west Africa. Presse Medicale 27(11): 522, 1998

Plasmodium falciparum malaria: type R1 resistance to quinine in East Africa. Presse Medicale 23(32): 1494, 1994

Plasmodium falciparum malaria: type R1 quinine resistance in East Africa. Presse Medicale 23(32): 1494, 1994

The lower susceptibility to Plasmodium falciparum malaria of Fulani of Burkina Faso (west Africa) is associated with low frequencies of classic malaria-resistance genes. Transactions of the Royal Society of Tropical Medicine and Hygiene 95(2): 149-152, 2001

What is the optimal dosage of quinine for patients with uncomplicated Plasmodium falciparum malaria imported from Africa?. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 39: 729, 1999

Artemether saved a patient with severe falciparum malaria after quinine treatment failure (R III type of quinine resistance). Southeast Asian Journal of Tropical Medicine and Public Health 25(4): 782-783, 1994

Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa. American Journal of Tropical Medicine and Hygiene 72(4): 407-409, 2005

Resistance of Plasmodium falciparum to amodiaquine and quinine in East Africa. Presse Medicale 15(19): 889, 1986

Resistance of Plasmodium falciparum to amodiaquine and quinine in eastern Africa. Presse Medicale 15(19): 889, 1986

In vitro susceptibility of Plasmodium falciparum to amodiaquine, mefloquine, quinine and chloroquine in Liberia, West Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 80(5): 761-762, 1986

Effectiveness of short-course quinine and single-dose sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria in Mpumalanga Province, South Africa. South African Medical Journal 91(7): 592-594, 2001

Intrarectal quinine versus intravenous or intramuscular quinine for treating Plasmodium falciparum malaria. Cochrane Database of Systematic Reviews 2009(1): Cd004009, 2009

Emergence of cross resistance between chloroquine and quinine in falciparum malaria africa 1986. Acta Leidensia 55: 217, 1987

Quinine alone versus quinine plus a pyrimethamine-sulfadoxine combination in the treatment of Plasmodium falciparum cerebral malaria. American journal of tropical medicine and hygiene 30(6): 1342-1343, 1981

Resistance of Plasmodium falciparum malaria to amodiaquine, chloroquine and quinine in the Madang Province of Papua New Guinea, 1990-1993. Papua and New Guinea Medical Journal 39(1): 16-22, 1996